tiprankstipranks
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market
INTI
Inhibitor Therapeutics
RESEARCH TOOLSreports
Want to see INTI full AI Analyst Report?

Inhibitor Therapeutics (INTI) Income Statement

30 Followers

Inhibitor Therapeutics Income Statement

Last quarter (Q4 2025), Inhibitor Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Inhibitor Therapeutics's net income was $-1.30M. See Inhibitor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.43M$ 3.66M$ 3.40M$ 657.93K$ 325.39K
Depreciation and Amortization
$ 0.00$ 3.66M$ 3.40M$ 657.93K$ 325.39K
EBITDA
$ -3.43M$ 318.00K$ 378.84K$ -74.00$ -325.00K
Operating Income
$ -3.43M$ -3.66M$ -3.40M$ -658.00K$ -325.00K
Other Income/Expenses
$ 126.32K$ 318.21K$ 378.84K$ 12.82M$ 26.76K
Pretax Income
$ -3.30M$ -3.34M$ -3.03M$ 12.16M$ -299.00K
Net Income
$ -3.30M$ -3.34M$ -3.03M$ 12.11M$ -299.00K
Per Share Metrics
Basic EPS
$ -0.02$ -0.02$ -0.02$ 0.03$ 0.00
Diluted EPS
$ -0.02$ -0.02$ -0.02$ 0.03$ 0.00
Weighted Average Shares Outstanding
 172.51M 172.26M 151.31M 366.18M 376.25M
Weighted Average Shares Outstanding (Diluted)
 172.51M 172.26M 171.95M 367.78M 376.25M
Currency in USD

Inhibitor Therapeutics Earnings and Revenue History